Does monastic life predispose to the risk of saint anthony's fire (herpes zoster)?

Clinical Infectious Diseases

Volumn 53, Issue 5, 2011, Pages 405-410

  Gaillat, Jacques ^a   Gajdos, Vincent ^b,c   Launay, Odile ^d,e   Malvy, Denis ^f   Demoures, Bruno ^g   Lewden, Lucie ^h   Pinchinat, Sybil ⁱ   Derrough, Tarik ^h   Sana, Claudine ^h   Caulin, Evelyne ^h   Soubeyrand, Benoît ^h  

^a Annecy General Hospital   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Institut Cochin   (France)

^f HÔPITAL SAINT ANDRÉ   (France)

^g Ocso Abbaye de Tamié   (France)

^h SANOFI PASTEUR   (France)

ⁱ Axonal Biostatem   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; EXPOSURE; FEMALE; FRANCE; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MALE; OBSERVATIONAL STUDY; OCCUPATIONAL HAZARD; POPULATION RESEARCH; PRIORITY JOURNAL; RELIGION; RELIGIOUS GROUP; RISK ASSESSMENT; RISK FACTOR; VARICELLA ZOSTER VIRUS;

AGED; CATHOLICISM; DATA COLLECTION; FEMALE; FRANCE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 80051995873     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir436     Document Type: Article

References (28)

1. Anderson RM, May RM eds. The basic model: statics. In: Infectious diseases of humans. Oxford: Oxford Science Publications, 1991; 70-1.
2. Khoshnood B, Debruyne M, Lanxcon F, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006; 25:41-4. (Pubitemid 43361474)
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58:9-20.
4. Arvin AM. Varicella-zoster virus. In: Fields BN, ed. Virology. Philadelphia: Lippincott-Raven, 1996; 2547-85.
5. Thomas SL, Hall JA. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4:26-33. (Pubitemid 38057055)
6. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20:2500-7. (Pubitemid 34615588)
7. Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. Lasting immunity to varicella in doctors study (LIVID study). J Am Acad Dermatol 1998; 38:763-5. (Pubitemid 28213723)
8. Terada K, Yoshihiro K, Kawano S, Morita T. Incidence of herpes zoster in pediatricians and family practitioners. Estimation of efficacy of varicella vaccine for protection against herpes zoster in the elderly. Kawasaki Med J 1994; 20:99-102.
9. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360:678-82. (Pubitemid 35232336)
10. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiol Infect 1992; 108:495-511.
11. Garnett GP, Ferguson NM. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev Med Virol 1996; 6:151-61. (Pubitemid 26297192)
12. Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 1999; 61:1031-64.
13. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunisation on the epidemiology of varicella zoster virus. Epidemiol Infect 2000; 125:651-69. (Pubitemid 32156853)
14. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 1994; 140:81-104. (Pubitemid 24205807)
15. Bernaola Iturbe E, Giménez Sanchez F, Baca Cots M, et al. Calendario vacunal de la Asociación Española de Pediatría: Recomendaciones 2009. An Pediatr (Barc) 2009; 70:72-82.
16. Conseil supérieur d'hygiène publique de France. Calendrier vaccinal 2004-Avis du Conseil supérieur d'hygiène publique de France. 19 mars 2004. Paris, France: BEH, 2004; 121-32.
17. Ministero Salute Italia. Piano nationale vaccini. Available at: http://www.ministerosalute.it/malattieInfettive/paginaInternaMalattieInfettive. jsp?menu=pianovaccini&id=651&lingua=italiano. Accessed 18 January 2011.
18. Office Fédéral de la Santé Publique (OFSP). Vaccination contre la varicelle. Recommandations de la Commission suisse pour les vaccinations (CSV) et de l'Office fédéral de la santé publique (OFSP). Vol 45. Paris, France: Bulletin de l'Office Fédéral de la Santé Publique, 2004; 846-8.
19. Ständige Impfkommission (STIKO) am Robert Koch-Institut. Begründung der STIKO für eine allgemeine Varizellenimpfung. Available at: http://www.rki.de/cln-151/nn-504678/DE/Content/Infekt/Impfen/STIKO/ Empfehlungen/Begruendung/variziellen.html.Accessed 18 January 2011.
20. Inglis S, Hall A, Pollard A, et al. Joint Committee on Vaccination and Immunisation (JCVI) Meetings 2009. Available at: http://www.dh.gov.uk/prod- consum-dh/groups/dh-digitalassets/@dh/@ab/documents/digitalasset/dh-103573.pdf. Accessed 18 January 2011.
21. Tseng HF, Smith N, Marcy SM, Sy LS, Chao CR, Jacobsen SJ. Risk factors of herpes zoster among children immunized with varicella vaccine. Results from a nested case-control study. Pediatr Infect Dis J 2010; 9:1-4.
22. Centers for Disease Control and Prevention. Immunization coverage in the United States-National Immunization Survey (NIS). Available at: http://www.cdc.gov/vaccines/stats-surv/#nis. Accessed 18 January 2011.
23. Alain S, Paccalin M, Larnaudie S, Perreaux F, Launay O. Impact de la vaccination de routine de l'enfant contre la varicelle sur l'épidé miologie du zona. Med Mal Infect 2009; 39:698-706.
24. Donahue JG, Kieke BA, Gargiullo PM, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health 2010; 100:1116-22.
25. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341-9. (Pubitemid 350060129)
26. Chidiac C, Bruxelle J, Daures JP, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62-9. (Pubitemid 32554504)
27. Réseau sentinelle de l'INSERM. Bilan annuel du réseau Sentinelles Janvier-Décembre 2008 - Rapport d'activité. 2008; 86-92. Available at: http://websenti.b3e.jussieu.fr/sentiweb/?rub=39. Accessed 18 January 2011.
28. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197(suppl 2):224-7.